A biosimilar (also known as follow-on biologic or subsequent entry biologic) is a biologic medical product. Biosimilars are officially approved versions of original "innovator" products, and can be manufactured when the original product's patent expires.
Rachana Singh · 5 min
Buyback Store · 7 min
Warner Williams · 2 min
Washington Post · 12 min
LapTec · 6 min
Usman Shahid · 5 min
Sign in to leave a comment.